<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="doi: 10.1073/pnas.1916585116 : Biological Sciences: Microbiology Divergent evolutionary trajectories of" exact="influenza" post="B viruses underlie their contemporaneous epidemic activity VirkRamandeep K.aJayakumarJayanthiahttp://orcid.org/0000-0003-4250-6459MendenhallIan"/>
 <result pre="under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).pnas.201916585.pdf Significance Two" exact="influenza" post="B viruses (Victoria and Yamagata) cocirculate in humans and"/>
 <result pre="to the estimated 290,000–650,000 annual influenza-attributed deaths. Here, we analysed" exact="influenza" post="B genomic data to understand the causes of a"/>
 <result pre="to understand the causes of a recent surge in human" exact="influenza" post="B infections. We found that evolution is acting differently"/>
 <result pre="has led to the cocirculation of a diverse group of" exact="influenza" post="B viruses. If this phenomenon continues, we could potentially"/>
 <result pre="could potentially witness the emergence of 3 or more distinct" exact="influenza" post="B viruses that could require their own vaccine component,"/>
 <result pre="viruses that could require their own vaccine component, thereby complicating" exact="influenza" post="vaccine formulation and highlighting the urgency of developing universal"/>
 <result pre="influenza vaccine formulation and highlighting the urgency of developing universal" exact="influenza" post="vaccines. Abstract Influenza B viruses have circulated in humans"/>
 <result pre="the reasons for which are unclear. By analyzing over 12,000" exact="influenza" post="B virus genomes, we describe the processes enabling the"/>
 <result pre="the long-term success and recent resurgence of epidemics due to" exact="influenza" post="B virus. We show that following prolonged diversification, both"/>
 <result pre="should be employed to monitor and develop robust protection against" exact="influenza" post="B morbidity and mortality. Overall, we show that long-term"/>
 <result pre="neuraminidase, are factors that contributed to successful circulation of diverse" exact="influenza" post="B clades. Further divergence of hemagglutinin variants with poor"/>
 <result pre="could potentially lead to circulation of 3 or more distinct" exact="influenza" post="B viruses, further complicating influenza vaccine formulation and highlighting"/>
 <result pre="of 3 or more distinct influenza B viruses, further complicating" exact="influenza" post="vaccine formulation and highlighting the urgent need for universal"/>
 <result pre="influenza vaccine formulation and highlighting the urgent need for universal" exact="influenza" post="vaccines. phylogeny genetic diversity natural selection antigenic vaccine Funding"/>
 <result pre="Siew-Chuan KoayDhanasekaran VijaykrishnaGavin JD SmithYvonne Su page-count: Two lineages of" exact="influenza" post="B viruses (&quot;B/Victoria/2/87-like�? and &quot;B/Yamagata/16/88-like,�? respectively, referred to as"/>
 <result pre="and the elderly being more susceptible to infection (1–3). Unlike" exact="influenza" post="A viruses, which periodically emerge from animals to cause"/>
 <result pre="and Yamagata lineages emerged as antigenic variants following divergence of" exact="influenza" post="B viruses during the 1970s, and both lineages have"/>
 <result pre="frequently mismatched with respect to the circulation of the dominant" exact="influenza" post="B lineage in a given season, resulting in low"/>
 <result pre="and Yamagata viruses evolve at a slower pace than in" exact="influenza" post="A virus lineages, although the Victoria lineage undergoes faster"/>
 <result pre="1A and 1B) (11). The development of greater diversity of" exact="influenza" post="B lineages raises a challenge to the existing quadrivalent"/>
 <result pre="diversity, reassortment plays a crucial role in the evolution of" exact="influenza" post="B viruses (9–11, 13). While Yamagata and Victoria viruses"/>
 <result pre="compatibility (9), as confirmed by in vitro experiments (14). Historically," exact="influenza" post="B virus epidemics have been characteristically low to sporadic"/>
 <result pre="low to sporadic in most countries during a year, with" exact="influenza" post="A viruses predominant in most countries. Since the first"/>
 <result pre="predominant in most countries. Since the first reports of high" exact="influenza" post="B virus activity in Europe in 2015, substantial epidemics"/>
 <result pre="indicating major changes in the evolutionary and epidemiological dynamics of" exact="influenza" post="B viruses (12, 15–19). Here, we analyzed all available"/>
 <result pre="influenza B viruses (12, 15–19). Here, we analyzed all available" exact="influenza" post="B genomic data (&amp;gt;12,000) in combination with 158 genomes"/>
 <result pre="the processes enabling the recent resurgence of epidemics due to" exact="influenza" post="B virus (see global epidemic activity in SI Appendix,"/>
 <result pre="sum, our results show that increases in epidemic dominance by" exact="influenza" post="B viruses is determined by a diverse set of"/>
 <result pre="than in the previous decades. Fig. 1. Phylodynamics of global" exact="influenza" post="B virus. Relative genetic diversities and temporal phylogenies of"/>
 <result pre="mutations within and between gene segments, and selection pressure of" exact="influenza" post="B viruses. (A) HA phylogeny of the Victoria lineage."/>
 <result pre="Victoria and Yamagata lineages is consistent with observations in seasonal" exact="influenza" post="A viruses, where emergence of between-subtype reassortants (e.g., between"/>
 <result pre="showing a correlation between reassortment and relative genetic diversity of" exact="influenza" post="B viruses. Selection Pressure of Victoria and Yamagata Lineages."/>
 <result pre="that the NA is contributing significantly to the evolution of" exact="influenza" post="B virus. Viral Migration Dynamics. We reconstructed the global"/>
 <result pre="virus. Viral Migration Dynamics. We reconstructed the global phylogeography of" exact="influenza" post="B viruses using the Markov fields model (20). We"/>
 <result pre="Appendix, Fig. S26). Fig. 4. Phylogeography and age distribution of" exact="influenza" post="B viruses. (A) Proportion of ancestral geographical location states"/>
 <result pre="(SA), and Southeast Asia (SEA). (C) Age density distribution of" exact="influenza" post="B virus by lineage. The violin plot indicates the"/>
 <result pre="2 decades reveal a dynamic pattern of evolution of seasonal" exact="influenza" post="viruses that were not observed previously using shorter time"/>
 <result pre="significant changes in the evolutionary landscapes of the 2 cocirculating" exact="influenza" post="B lineages, Victoria and Yamagata. For the Victoria lineage,"/>
 <result pre="The observation of HA deletion variants is not unprecedented in" exact="influenza" post="B viruses; the influenza B prototype strain B/Lee/1940 possessed"/>
 <result pre="deletion variants is not unprecedented in influenza B viruses; the" exact="influenza" post="B prototype strain B/Lee/1940 possessed an amino acid deletion"/>
 <result pre="HA protein, they may be crucial for antigenic properties of" exact="influenza" post="B viruses (24). At the time of writing, the"/>
 <result pre="B viruses (24). At the time of writing, the current" exact="influenza" post="vaccine strain selected for the Victoria lineage was the"/>
 <result pre="antigenically distinct variants. The circulation of 3 or more distinct" exact="influenza" post="B viruses would drastically complicate influenza vaccine formulation. We"/>
 <result pre="3 or more distinct influenza B viruses would drastically complicate" exact="influenza" post="vaccine formulation. We found that the NA of Yamagata"/>
 <result pre="that coincide with global epidemics of Yamagata viruses (16–19). The" exact="influenza" post="vaccine strain for the Yamagata lineage (B/Phuket/3073/2013-like) has remain"/>
 <result pre="cross-react with older viruses. Increasing awareness of the importance of" exact="influenza" post="virus NA immunity has prompted recent efforts to understand"/>
 <result pre="anti-NA antibodies can significantly reduce virus titers and shedding of" exact="influenza" post="B viruses (27) and lower the duration of illness"/>
 <result pre="B viruses (27) and lower the duration of illness in" exact="influenza" post="A/H1N1 virus (28). Crucially, anti-NA antibodies can broadly cross-react"/>
 <result pre="broadly cross-react against H1N1 and H3N2 subtype viruses, but current" exact="influenza" post="vaccines cannot induce an efficient NA response (29). Furthermore,"/>
 <result pre="we have revealed key molecular processes affecting the evolution of" exact="influenza" post="B virus that have contributed to immune escape and"/>
 <result pre="on the antigenic and genetic evolution and global circulation of" exact="influenza" post="B virus. Addressing these aspects can potentially aid modeling"/>
 <result pre="of epidemic outbreaks, and also inform the development of universal" exact="influenza" post="vaccines that are the cornerstone of current research efforts"/>
 <result pre="RT-PCR. Influenza A virus was detected in 1,493 samples and" exact="influenza" post="B in 654 samples. A subset of influenza B"/>
 <result pre="samples and influenza B in 654 samples. A subset of" exact="influenza" post="B samples was selected for full genome sequencing using"/>
 <result pre="swabs and followed by RT-PCR amplification of whole genome of" exact="influenza" post="B (32, 33). The PCR products were quantified using"/>
 <result pre="UGENE, and consensus sequences were obtained. A total of 158" exact="influenza" post="B genomes (76 Victoria and 82 Yamagata) were generated."/>
 <result pre="Genomic Analysis of Influenza B Viruses. We downloaded &amp;gt;12,000 global" exact="influenza" post="B genomes (as of May 30, 2019) from National"/>
 <result pre="2008 to 2019. To investigate the evolutionary dynamics of recent" exact="influenza" post="B outbreaks, we first reconstructed the global evolution using"/>
 <result pre="phylogenies. Reassortment Analysis. Based on the global HA phylogeny of" exact="influenza" post="B lineages, the Victoria and Yamagata split into 2"/>
 <result pre="Influenza B Viruses. To infer the spatial-temporal dynamics of each" exact="influenza" post="B lineage, a Bayesian Stochastic Search Variable Selection (BSSVS)"/>
 <result pre="Global Host Age Distribution. We downloaded the global sequences of" exact="influenza" post="B viruses (Victoria: 5,302 and Yamagata: 7,360) from 2008"/>
 <result pre="Proportion Positive (GRIPP) Working Group, Global role and burden of" exact="influenza" post="in pediatric respiratory hospitalizations, 1982-2012: A systematic analysis. PLoS"/>
 <result pre="network, Clinical characteristics are similar across type A and B" exact="influenza" post="virus infections. PLoS One10, e0136186 (2015).26325069 4ShawM. W.et al.,"/>
 <result pre="4ShawM. W.et al., Reappearance and global spread of variants of" exact="influenza" post="B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons."/>
 <result pre="2000-2001 and 2001-2002 seasons. Virology303, 1–8 (2002).12482653 5TisaV.et al., Quadrivalent" exact="influenza" post="vaccine: A new opportunity to reduce the influenza burden."/>
 <result pre="al., Quadrivalent influenza vaccine: A new opportunity to reduce the" exact="influenza" post="burden. J. Prev. Med. Hyg.57, E28–E33 (2016).27346937 6HeikkinenT., IkonenN.,"/>
 <result pre="Prev. Med. Hyg.57, E28–E33 (2016).27346937 6HeikkinenT., IkonenN., ZieglerT., Impact of" exact="influenza" post="B lineage-level mismatch between trivalent seasonal influenza vaccines and"/>
 <result pre="ZieglerT., Impact of influenza B lineage-level mismatch between trivalent seasonal" exact="influenza" post="vaccines and circulating viruses, 1999-2012. Clin. Infect. Dis.59, 1519–1524"/>
 <result pre="1999-2012. Clin. Infect. Dis.59, 1519–1524 (2014).25139969 7SunW.et al., Development of" exact="influenza" post="B universal vaccine candidates using the &quot;Mosaic�? hemagglutinin approach."/>
 <result pre="Virol.93, e00333-19 (2019).30944178 8BedfordT.et al., Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic drift. Nature523, 217–220 (2015).26053121 9DudasG.,"/>
 <result pre="drift. Nature523, 217–220 (2015).26053121 9DudasG., BedfordT., LycettS., RambautA., Reassortment between" exact="influenza" post="B lineages and the emergence of a coadapted PB1-PB2-HA"/>
 <result pre="Evol.32, 162–172 (2015).25323575 10VijaykrishnaD.et al., The contrasting phylodynamics of human" exact="influenza" post="B viruses. eLife4, e05055 (2015).25594904 11LangatP.et al., Genome-wide evolutionary"/>
 <result pre="viruses. eLife4, e05055 (2015).25594904 11LangatP.et al., Genome-wide evolutionary dynamics of" exact="influenza" post="B viruses on a global scale. PLoS Pathog.13, e1006749"/>
 <result pre="(2017).29284042 12BarrI. G., VijaykrishnaD., SullivanS. G., Differential age susceptibility to" exact="influenza" post="B/Victoria lineage viruses in the 2015 Australian influenza season."/>
 <result pre="susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian" exact="influenza" post="season. Euro Surveill.21, 30118 (2016). 13ChenR., HolmesE. C., The"/>
 <result pre="30118 (2016). 13ChenR., HolmesE. C., The evolutionary dynamics of human" exact="influenza" post="B virus. J. Mol. Evol.66, 655–663 (2008).18504518 14KimJ. I.et"/>
 <result pre="compatibility between PB1, PB2, and HA genes of the two" exact="influenza" post="B virus lineages in mammalian cells. Sci. Rep.6, 27480"/>
 <result pre="15collab: World Health Organization, WHO recommendations on the composition of" exact="influenza" post="virus vaccines. https://www.who.int/influenza/vaccines/virus/recommendations/en/. Accessed 9 September 2019. 16AdlhochC., SnackenR.,"/>
 <result pre="MelidouA., IonescuS., PenttinenP.; collab: The European Influenza Surveillance Network, Dominant" exact="influenza" post="A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and"/>
 <result pre="States during the 2017-18 season and composition of the 2018-19" exact="influenza" post="vaccine. MMWR Morb. Mortal. Wkly. Rep.67, 634–642 (2018).29879098 18SkowronskiD."/>
 <result pre="Rep.67, 634–642 (2018).29879098 18SkowronskiD. M.et al., Early season co-circulation of" exact="influenza" post="A(H3N2) and B(Yamagata): Interim estimates of 2017/18 vaccine effectiveness,"/>
 <result pre="2018. Euro Surveill.23, 18-00035 (2018). 19KorsunN. S.et al., Predominance of" exact="influenza" post="B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season."/>
 <result pre="Comput. Biol.5, e1000520 (2009).19779555 21TanY.et al., Differing epidemiological dynamics of" exact="influenza" post="B virus lineages in Guangzhou, southern China, 2009-2010. J."/>
 <result pre="J. Virol.87, 12447–12456 (2013).24027322 22SkowronskiD. M.et al., Age-related differences in" exact="influenza" post="B infection by lineage in a community-based sentinel system,"/>
 <result pre="J. Infect. Dis.216, 697–702 (2017).28934439 23NeromeR.et al., Evolutionary characteristics of" exact="influenza" post="B virus since its first isolation in 1940: Dynamic"/>
 <result pre="with amino acid deletions clarify a neutralizing epitope specific for" exact="influenza" post="B virus Victoria group strains. J. Gen. Virol.82, 2169–2172"/>
 <result pre="September 2019. 26collab: Centers for Disease Control and Prevention, Seasonal" exact="influenza" post="vaccine effectiveness, 2017-2018. https://www.cdc.gov/flu/vaccines-work/2017-2018.html. Accessed 9 September 2019. 27McMahonM.et"/>
 <result pre="9 September 2019. 27McMahonM.et al., Mucosal immunity against neuraminidase prevents" exact="influenza" post="B virus transmission in Guinea Pigs. MBio10, e00560-19 (2019).31113896"/>
 <result pre="al., Pre-existing anti-neuraminidase antibodies are associated with shortened duration of" exact="influenza" post="A (H1N1)pdm virus shedding and illness in naturally infected"/>
 <result pre="changes to the lateral surface of the neuraminidase head of" exact="influenza" post="A virus. Nat. Microbiol.4, 1024–1034 (2019).30886361 31HoffmannE.et al., Rescue"/>
 <result pre="A virus. Nat. Microbiol.4, 1024–1034 (2019).30886361 31HoffmannE.et al., Rescue of" exact="influenza" post="B virus from eight plasmids. Proc. Natl. Acad. Sci."/>
 <result pre="Proc. Natl. Acad. Sci. U.S.A.99, 11411–11416 (2002).12172012 32ZhouB.et al., Universal" exact="influenza" post="B virus genomic amplification facilitates sequencing, diagnostics, and reverse"/>
 <result pre="LohT. P., KoayE. S., Contamination-controlled high-throughput whole genome sequencing for" exact="influenza" post="A viruses using the MiSeq sequencer. Sci. Rep.6, 33318"/>
 <result pre="8 July 2019. 44SuY. C. F.et al., Phylodynamics of H1N1/2009" exact="influenza" post="reveals the transition from host adaptation to immune-driven selection."/>
 <result pre="Commun.6, 7952 (2015).26245473 45NagarajanN., KingsfordC., GiRaF: Robust, computational identification of" exact="influenza" post="reassortments via graph mining. Nucleic Acids Res.39, e34 (2011).21177643"/>
 <result pre="(2008).17874105 52BahlJ.et al., Temporally structured metapopulation dynamics and persistence of" exact="influenza" post="A H3N2 virus in humans. Proc. Natl. Acad. Sci."/>
 <result pre="PascualM., Global migration dynamics underlie evolution and persistence of human" exact="influenza" post="A (H3N2). PLoS Pathog.6, e1000918 (2010).20523898"/>
</results>
